# Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema

> **NCT05582577** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Shahid Beheshti University of Medical Sciences** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **COMBINATION_PRODUCT:** Intravitreal bevacizumab injection with subthreshold micropulse laser
- **DRUG:** Intravitreal bevacizumab injection alone

## Key facts

- **NCT ID:** NCT05582577
- **Lead sponsor:** Shahid Beheshti University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-15
- **Primary completion:** 2023-10-15
- **Final completion:** 2023-12-15
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05582577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05582577, "Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05582577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*